5-[(3R)-4-(2-amino-6-methylpyrimidin-4-yl)-1,4-oxazepan-3-yl]-4-chloro-2-(methylsulfonylmethyl)phenol
C18H23ClN4O4S — CID 146215363
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[(3R)-4-(2-amino-6-methylpyrimidin-4-yl)-1,4-oxazepan-3-yl]-4-chloro-2-(methylsulfonylmethyl)phenol
5-[(3R)-4-(2-amino-6-methylpyrimidin-4-yl)-1,4-oxazepan-3-yl]-4-chloro-2-(methylsulfonylmethyl)phenol (PubChem CID 146215363) has the molecular formula C18H23ClN4O4S and a molecular weight of 426.93 g/mol. Its IUPAC name is 5-[(3R)-4-(2-amino-6-methylpyrimidin-4-yl)-1,4-oxazepan-3-yl]-4-chloro-2-(methylsulfonylmethyl)phenol.
Molecular Properties
| Compound Name | 5-[(3R)-4-(2-amino-6-methylpyrimidin-4-yl)-1,4-oxazepan-3-yl]-4-chloro-2-(methylsulfonylmethyl)phenol |
|---|---|
| PubChem CID | 146215363 |
| Molecular Formula | C18H23ClN4O4S |
| Molecular Weight | 426.93 g/mol |
| Exact Mass | 426.11 |
| IUPAC Name | 5-[(3R)-4-(2-amino-6-methylpyrimidin-4-yl)-1,4-oxazepan-3-yl]-4-chloro-2-(methylsulfonylmethyl)phenol |
| SMILES | Cc1cc(N2CCCOC[C@H]2c2cc(O)c(CS(C)(=O)=O)cc2Cl)nc(N)n1 |
| InChI | InChI=1S/C18H23ClN4O4S/c1-11-6-17(22-18(20)21-11)23-4-3-5-27-9-15(23)13-8-16(24)12(7-14(13)19)10-28(2,25)26/h6-8,15,24H,3-5,9-10H2,1-2H3,(H2,20,21,22)/t15-/m0/s1 |
| InChIKey | QDEBYWFTQIGLNF-HNNXBMFYSA-N |
| XLogP | 2.24 |
| TPSA | 118.64 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 426.93 |
| LogP ≤ 5 | 2.24 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146215363 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.